Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The Annals of Pharmacotherapy|June 3, 2022
Omadacycline and <i>Clostridioides difficile</i>: A Systematic Review of Preclinical and Clinical EvidenceKevin W Garey, Warren Rose, Kyle Gunter, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2025
Monthly dalbavancin dosing for suppressive therapy: a pharmacokinetic estimation analysis and case seriesWesley D Kufel, Kristen Tudahl, Paul Hutson, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2013
Ceftaroline restores daptomycin activity against daptomycin-nonsusceptible vancomycin-resistant Enterococcus faeciumGeorge Sakoulas, Warren Rose, Poochit Nonejuie, et al.
Infectious Diseases and Therapy|December 19, 2014
Evaluation of High-Dose Daptomycin Versus Vancomycin Alone or Combined with Clarithromycin or Rifampin Against Staphylococcus aureus and S. epidermidis in a Novel In Vitro PK/PD Model of Bacterial BiofilmAshley D Hall Snyder, Celine Vidaillac, Warren Rose, et al.
Antimicrobial Resistance and Infection Control|November 3, 2018
<i>Clostridium difficile</i> infection perceptions and practices: a multicenter qualitative study in South AfricaLaurel Legenza, Susanne Barnett, Warren Rose, et al.
Journal of Clinical Microbiology|November 16, 2007
Evaluation of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycinGeorge Sakoulas, Warren Rose, Michael J Rybak, et al.
Pharmacotherapy|November 29, 2007
Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomesSusan L Davis, Peggy S McKinnon, Levi M Hall, et al.
Pharmacology Research & Perspectives|March 8, 2018
RNA expression profiling in sulfamethoxazole-treated patients with a range of in vitro lymphocyte cytotoxicity phenotypesJennifer M Reinhart, Warren Rose, Daniel J Panyard, et al.
Antimicrobial Agents and Chemotherapy|November 23, 2016
Classical β-Lactamase Inhibitors Potentiate the Activity of Daptomycin against Methicillin-Resistant Staphylococcus aureus and Colistin against Acinetobacter baumanniiGeorge Sakoulas, Warren Rose, Andrew Berti, et al.
Open Forum Infectious Diseases|May 2, 2022
Potent Activity of Ertapenem Plus Cefazolin Within Staphylococcal Biofilms: A Contributing Factor in the Treatment of Methicillin-Susceptible <i>Staphylococcus aureus</i> EndocarditisJessica Gilbertie, Erlinda R Ulloa, Jennifer C Daiker, et al.
Pageof 3